PL2808325T3 - Podstawione azole, przeciwwirusowy składnik czynny, kompozycja farmaceutyczna, sposób ich wytwarzania i stosowania - Google Patents
Podstawione azole, przeciwwirusowy składnik czynny, kompozycja farmaceutyczna, sposób ich wytwarzania i stosowaniaInfo
- Publication number
- PL2808325T3 PL2808325T3 PL14002393T PL14002393T PL2808325T3 PL 2808325 T3 PL2808325 T3 PL 2808325T3 PL 14002393 T PL14002393 T PL 14002393T PL 14002393 T PL14002393 T PL 14002393T PL 2808325 T3 PL2808325 T3 PL 2808325T3
- Authority
- PL
- Poland
- Prior art keywords
- production
- pharmaceutical composition
- active ingredient
- substituted azoles
- viral active
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 230000000840 anti-viral effect Effects 0.000 title 1
- 150000003851 azoles Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010148813/04A RU2452735C1 (ru) | 2010-11-30 | 2010-11-30 | Замещенные азолы, противовирусный активный компонент, фармацевтическая композиция, способ получения и применения |
| EP11844522.0A EP2657231A4 (en) | 2010-11-30 | 2011-11-28 | SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE INGREDIENT, PHARMACEUTICAL COMPOSITION AND PROCESS FOR PREPARING AND USING SAME |
| EP14002393.8A EP2808325B1 (en) | 2010-11-30 | 2011-11-28 | Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2808325T3 true PL2808325T3 (pl) | 2018-03-30 |
Family
ID=46172446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14002393T PL2808325T3 (pl) | 2010-11-30 | 2011-11-28 | Podstawione azole, przeciwwirusowy składnik czynny, kompozycja farmaceutyczna, sposób ich wytwarzania i stosowania |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9428491B2 (pl) |
| EP (2) | EP2808325B1 (pl) |
| JP (1) | JP5994131B2 (pl) |
| KR (1) | KR101771093B1 (pl) |
| AU (1) | AU2011337290B2 (pl) |
| CA (1) | CA2832426C (pl) |
| DK (1) | DK2808325T3 (pl) |
| EA (1) | EA020949B1 (pl) |
| ES (1) | ES2652170T3 (pl) |
| GE (1) | GEP20156263B (pl) |
| HU (1) | HUE037742T2 (pl) |
| LT (1) | LT2808325T (pl) |
| PL (1) | PL2808325T3 (pl) |
| RU (1) | RU2452735C1 (pl) |
| UA (1) | UA111832C2 (pl) |
| WO (1) | WO2012074437A2 (pl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA118080C2 (uk) | 2009-06-11 | 2018-11-26 | Еббві Айрленд Анлімітед Компані | Противірусні сполуки |
| US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
| NZ605440A (en) | 2010-06-10 | 2014-05-30 | Abbvie Bahamas Ltd | Solid compositions comprising an hcv inhibitor |
| EP2651926A4 (en) * | 2010-12-15 | 2014-07-09 | Abbvie Inc | ANTI-VIRAL COMPOUNDS |
| US8552047B2 (en) | 2011-02-07 | 2013-10-08 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US9546160B2 (en) | 2011-05-12 | 2017-01-17 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
| US9034832B2 (en) | 2011-12-29 | 2015-05-19 | Abbvie Inc. | Solid compositions |
| US9326973B2 (en) | 2012-01-13 | 2016-05-03 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| RU2518369C1 (ru) * | 2013-02-07 | 2014-06-10 | Общество с ограниченной ответственностью "Интеллектуальный Диалог" | Алкил [2-(2-{5-[4-(4-{2-[1-(2-метоксикарбониламино-ацетил)-пирролидин-2-ил]-3н-имидазол-4-ил}-фенил)-бута-1,3-диинил]-1н-имидазол-2-ил}-пирролидин-1-ил)-2-оксо-этил]-карбамат, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний |
| RU2507201C1 (ru) * | 2013-02-07 | 2014-02-20 | Александр Васильевич Иващенко | Алкил [(s)-1-((s)-2-{5-[4-(4-{2-[(s)-1-((s)-2-метоксикарбониламино-3-метил-бутирил)-пирролидин-2-ил]-3н-имидазол-4-ил}-бута-1,3-диинил)-фенил]-1н-имидазол-2-ил}-пирролидин-1-карбонил)-2-метил-пропил]-карбамат нафталин-1,5-дисульфонат, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний |
| US11484534B2 (en) | 2013-03-14 | 2022-11-01 | Abbvie Inc. | Methods for treating HCV |
| US20150023913A1 (en) | 2013-07-02 | 2015-01-22 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
| US9717712B2 (en) | 2013-07-02 | 2017-08-01 | Bristol-Myers Squibb Company | Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus |
| US9775831B2 (en) | 2013-07-17 | 2017-10-03 | Bristol-Myers Squibb Company | Combinations comprising biphenyl derivatives for use in the treatment of HCV |
| EP3089757A1 (en) | 2014-01-03 | 2016-11-09 | AbbVie Inc. | Solid antiviral dosage forms |
| WO2016123073A1 (en) | 2015-01-26 | 2016-08-04 | Children's Medical Center Corporation | Treatment of infectious diseases |
| US10617675B2 (en) | 2015-08-06 | 2020-04-14 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US9790207B2 (en) * | 2015-09-04 | 2017-10-17 | Alexandre Vasilievich Ivachtchenko | Pan-genomic inhibitors of NS5A protein encoded by HCV, pharmaceutical compositions, intermediates for inhibitor synthesis, and their synthesis and application methods |
| RU2659388C1 (ru) | 2017-02-28 | 2018-07-02 | Васильевич Иващенко Александр | Нуклеотиды, включающие N-[(S)-1-циклобутоксикарбонил]фосфорамидатный фрагмент, их аналоги и их применение |
| RU2650610C1 (ru) | 2017-02-28 | 2018-04-16 | Васильевич Иващенко Александр | Противовирусная композиция и способ ее применения |
| RU2717101C1 (ru) | 2019-06-03 | 2020-03-18 | Андрей Александрович Иващенко | Анелированные 9-гидрокси-1,8-диоксо-1,3,4,8-тетрагидро-2Н-пиридо[1,2-a]пиразин-7-карбоксамиды - ингибиторы интегразы ВИЧ, способы их получения и применения |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7745636B2 (en) * | 2006-08-11 | 2010-06-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7659270B2 (en) * | 2006-08-11 | 2010-02-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7759495B2 (en) * | 2006-08-11 | 2010-07-20 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8329159B2 (en) | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7741347B2 (en) * | 2007-05-17 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8629171B2 (en) | 2007-08-08 | 2014-01-14 | Bristol-Myers Squibb Company | Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt |
| US7728027B2 (en) | 2007-08-08 | 2010-06-01 | Bristol-Myers Squibb Company | Process for synthesizing compounds useful for treating hepatitis C |
| WO2010065668A1 (en) * | 2008-12-03 | 2010-06-10 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
| TWI438200B (zh) | 2009-02-17 | 2014-05-21 | 必治妥美雅史谷比公司 | Ｃ型肝炎病毒抑制劑 |
| WO2010096462A1 (en) | 2009-02-17 | 2010-08-26 | Enanta Pharmaceuticals, Inc | Linked diimidazole derivatives |
| US8637561B2 (en) * | 2009-02-17 | 2014-01-28 | Enanta Pharmaceuticals, Inc. | Linked diimidazole derivatives |
| WO2010096777A1 (en) | 2009-02-23 | 2010-08-26 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
| SG174883A1 (en) | 2009-03-27 | 2011-11-28 | Presidio Pharmaceuticals Inc | Fused ring inhibitors of hepatitis c |
| WO2010111673A1 (en) | 2009-03-27 | 2010-09-30 | Presidio Pharmaceuticals, Inc. | Substituted bicyclic hcv inhibitors |
| US8796466B2 (en) | 2009-03-30 | 2014-08-05 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| TWI476190B (zh) * | 2009-03-30 | 2015-03-11 | 必治妥美雅史谷比公司 | Ｃ型肝炎病毒抑制劑 |
| TW201038559A (en) | 2009-04-09 | 2010-11-01 | Bristol Myers Squibb Co | Hepatitis C virus inhibitors |
| PT3309157T (pt) * | 2009-05-13 | 2019-12-02 | Gilead Pharmasset Llc | Compostos antivirais |
| US20110281910A1 (en) * | 2009-11-12 | 2011-11-17 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
-
2010
- 2010-11-30 RU RU2010148813/04A patent/RU2452735C1/ru active
-
2011
- 2011-11-28 WO PCT/RU2011/000932 patent/WO2012074437A2/ru not_active Ceased
- 2011-11-28 HU HUE14002393A patent/HUE037742T2/hu unknown
- 2011-11-28 EA EA201300494A patent/EA020949B1/ru not_active IP Right Cessation
- 2011-11-28 GE GEAP201113213A patent/GEP20156263B/en unknown
- 2011-11-28 KR KR1020137017088A patent/KR101771093B1/ko not_active Expired - Fee Related
- 2011-11-28 CA CA2832426A patent/CA2832426C/en not_active Expired - Fee Related
- 2011-11-28 AU AU2011337290A patent/AU2011337290B2/en not_active Ceased
- 2011-11-28 JP JP2013541951A patent/JP5994131B2/ja not_active Expired - Fee Related
- 2011-11-28 EP EP14002393.8A patent/EP2808325B1/en not_active Not-in-force
- 2011-11-28 DK DK14002393.8T patent/DK2808325T3/en active
- 2011-11-28 LT LTEP14002393.8T patent/LT2808325T/lt unknown
- 2011-11-28 US US13/990,428 patent/US9428491B2/en active Active
- 2011-11-28 PL PL14002393T patent/PL2808325T3/pl unknown
- 2011-11-28 UA UAA201307488A patent/UA111832C2/uk unknown
- 2011-11-28 ES ES14002393.8T patent/ES2652170T3/es active Active
- 2011-11-28 EP EP11844522.0A patent/EP2657231A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011337290B2 (en) | 2016-06-16 |
| GEP20156263B (en) | 2015-03-25 |
| EP2808325A1 (en) | 2014-12-03 |
| EA201300494A1 (ru) | 2013-08-30 |
| EP2808325B1 (en) | 2017-10-25 |
| RU2452735C1 (ru) | 2012-06-10 |
| UA111832C2 (uk) | 2016-06-24 |
| EP2657231A2 (en) | 2013-10-30 |
| EP2657231A4 (en) | 2014-01-15 |
| AU2011337290A1 (en) | 2013-05-09 |
| CA2832426C (en) | 2017-07-18 |
| DK2808325T3 (en) | 2018-01-02 |
| JP2013544281A (ja) | 2013-12-12 |
| WO2012074437A2 (ru) | 2012-06-07 |
| ES2652170T3 (es) | 2018-01-31 |
| CA2832426A1 (en) | 2012-06-07 |
| KR101771093B1 (ko) | 2017-08-24 |
| LT2808325T (lt) | 2018-02-12 |
| HUE037742T2 (hu) | 2018-09-28 |
| US20130253008A1 (en) | 2013-09-26 |
| EA020949B1 (ru) | 2015-02-27 |
| US9428491B2 (en) | 2016-08-30 |
| KR20140027076A (ko) | 2014-03-06 |
| JP5994131B2 (ja) | 2016-09-21 |
| WO2012074437A3 (ru) | 2012-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT2808325T (lt) | Pakeistieji azolai, antivirusinis aktyvus ingredientas, farmacinė kompozicija, jų gavimo ir panaudojimo būdas | |
| EP2522653A4 (en) | BIGUANIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE BIGUANIDE DERIVATIVE AS AN ACTIVE SUBSTANCE | |
| IL233154A (en) | Compounds, pharmaceuticals containing them and their uses | |
| IL224288A (en) | Derivatives of converted pyrazolamide, pharmaceutical preparations containing them and their use | |
| EP2947084B8 (en) | Five-and-six-membered heterocyclic compound, and preparation method, pharmaceutical composition and use thereof | |
| IL223983A (en) | Compounds of heterocyclic benzene alkynyl, containing pharmaceutical preparations and their use | |
| ZA201208198B (en) | Picolinamide and pyrimidine-4-carboxamine compounds, process for preparing and pharmaceutical composition comprising the same | |
| IL235767A (en) | Preserved pyrolidines, pharmaceuticals containing them and their uses | |
| IL223463A (en) | Urea History, Pharmaceutical Preparations Containing and Uses | |
| IL232217A (en) | Derivatives of Azul, pharmaceutical preparations containing them and their use | |
| ZA201301463B (en) | Pharmaceutical compositions for calonolides,their derivatives and analogues,and process for producing the same | |
| IL232035A (en) | These heterocyclic compounds, these compounds as a medicine and a pharmaceutical composition containing them | |
| PL2562172T3 (pl) | Pochodne sfelaktonu, ich kompozycje farmaceutyczne, sposoby wytwarzania i zastosowania | |
| IL236057B (en) | History of 4,2,1-triazine-6-carboxamide and pharmaceutical preparations containing them | |
| WO2011009938A3 (en) | Stambomycin and derivatives, their production and their use as drugs | |
| PL2770827T3 (pl) | Kompozycja, sposób otrzymywania kompozycji i zawierająca ją formulacja fitosanitarna | |
| EP2924042A4 (en) | BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| ZA201309559B (en) | Comptothecin derivative, method for preparing same, pharmaceutical composition and use thereof | |
| IL232061A (en) | The heterocyclic compound in the bicycle, a pharmaceutical product containing it and its use | |
| IL228705A (en) | Derivatives of Reliable Phenoxy-Ethyl, Pharmaceutical Preparations Containing and Using Them | |
| SI2928861T1 (sl) | Aminociklobutan derivati, postopek priprave le-teh in uporaba le-teh kot zdravila | |
| IL225105A (en) | Heterocyclic compounds, their process, their pharmaceutical preparations and their use in the preparation of drugs | |
| IL226183A0 (en) | A pharmaceutical preparation and a dosage form comprising dronedrone, and a method for their preparation | |
| IL221737A (en) | Its compound or salt, a pharmaceutical preparation containing it and its uses | |
| IL225440A (en) | Cyclohexane derivatives, preparations containing them and their uses |